Clinical distribution and drug susceptibility and biological membrane type of Candida albicans infection

An-quan SHANG,Jian WU,Hong-chao PAN,Wei-wei WANG,Xiao-min LIU,Jun WEI
DOI: https://doi.org/10.11816/cn.ni.2016-152437
2016-01-01
Abstract:OBJECTIVE To comparatively analyze the clinical distribution ,drug susceptibility and capacity of bio‐logical membrane production of Candida albicans infection ,so as to provide a scientific basis for antifungal agents use in a rational way in clinic .METHODS A total of 7612 strains of fungi were isolated and collected from the pa‐tients'samples in the hospital from Jan .2013 to Aug .2015 .The bacteria were isolated and cultured according to the national clinical laboratory operation rules ,using VITEK‐2 Compact analyzer to identify species ,using paper K‐B to give the test of drug sensitivity in vitro ,using WHONET 5 .6 software for statistical analysis ,and crystal violet staining method for quantitative analysis of C . albicans biological membrane .RESULTS A total of 1366 strains of C .albicans were isolated ,accounting for 17 .9% ;C .albicans was mainly isolated from pneumology de‐partment (389 strains) and emergency department (241 strains) ,accounting for 28 .5% and 17 .6% respectively ;C .albicans samples were mainly from sputum(68 .3% ) ,followed by urine(10 .5% ) and secretion (5 .8% ) .The drug sensitive rate of C .albicans to amphotericin B ,voriconazole ,fluconazole ,flucytosine and itraconazole were respectively 100 .0% ,100 .0% ,99 .9% ,99 .8% and 98 .0% ;standard strain SC5314 was high production of biological membrane and among the 1366 strains of C . albicans ,325 strains of low production biological mem‐brane ,243 strains of production biological membrane and 798 strains of high production biological membrane were isolated in clinic .CONCLUSION C . albicans has high sensitivity to amphotericin B ,voriconazole ,fluconazole , flucytosine and itraconazole .In view of the difference clinical distribution of C .albicans ,antifungal drugs should be chosen reasonably in clinical treatment .At the same time the enhancement of monitoring fungal resistance can help to reduce the generation of drug‐resistant strains ,promoting the study of relation between biological mem‐brane produce ability and the resistance mechanism of C .albicans .
What problem does this paper attempt to address?